Overview

thiotepa


'thiotepa' can also refer to...

Thiotepa

Thio-tepa

Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer

17PIntravenous thiotepa for treatment of leptomeningeal carcinomatosis: Retrospective case series

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin

Chemical Degradation of Wastes of Antineoplastic Agents Amsacrine, Azathioprine, Asparaginase and Thiotepa

Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa

P3–009NON-THIOTEPA-BASED HDT AND ASCT FOR RELAPSED/REFRACTORY SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin–paclitaxel-containing regimens in metastatic breast cancer (MBC)

Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma

EPT-09TANDEM THIOTEPA-BASED CONDITIONING AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN WITH HIGH-RISK CENTRAL NERVOUS SYSTEM TUMORS

Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma†

Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study

Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hämato-Onkologie OSHO-53 phase II study

MB-03LONG TERM FOLLOW-UP OF PATIENTS WITH METASTATIC (M+) AND OTHER HIGH-RISK MEDULLOBLASTOMA WITH TAILORED-DOSES HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) CRANIOSPINAL IRRADIATION (CSI) PLUS/MINUS HIGH-DOSE THIOTEPA

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

Trade name for triethylenethiophosphoramide, a mutagenic, alkylating agent.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.